Literature DB >> 22025155

Progress in molecular targeted therapy for thyroid cancer: vandetanib in medullary thyroid cancer.

Benjamin Solomon, Danny Rischin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22025155     DOI: 10.1200/JCO.2011.37.8638

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Oncogenesis of Thyroid Cancer

Authors:  Enas Younis
Journal:  Asian Pac J Cancer Prev       Date:  2017-05-01

2.  Thyroid Cancer Epidemic: A Peril or an Alarm?

Authors:  Zahra Nozhat; Mehdi Hedayati; Feridoun Azizi
Journal:  Int J Endocrinol Metab       Date:  2015-10-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.